Jinnaling refined tablets have obtained many national patents.

Four projects. Jinnaling refined tablets were developed by Beijing Cantiny Pharmaceutical Co., Ltd., and the raw materials used were certified by Hubei Science and Technology Department for many scientific and technological achievements, and applied for and obtained four national invention patents. It is a product that can prevent cardiovascular diseases. The main component is sturgeon protein peptide, which has a good effect on removing toxins from blood and accelerating metabolism.